J&J Medical Connect
CAPLYTA®

(lumateperone)

+ Save link
J&J Medical Connect

Connect with us

Connect with us

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

CAPLYTA® (lumateperone)

Medical Information

CAPLYTA - Use in Patients with Parkinson’s Disease

Last Updated: 11/11/2025

SUMMARY  

  • CAPLYTA is not indicated for use in patients with Parkinson’s disease.
  • Clinical studies designed to evaluate the efficacy and/or safety of CAPLYTA in patients with Parkinson’s disease have not been performed.  

Literature Search

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, and DERWENT® (and/or other resources, including internal/external databases) conducted on 13 October 2025 did not identify any relevant citations pertaining to this topic.